Elicio Therapeutics, Inc.
ELTX
$2.18
-$0.17-7.23%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -37.84M | -40.19M | -39.57M | -45.86M | -54.61M |
| Total Depreciation and Amortization | 1.14M | 1.14M | 1.13M | 1.15M | 1.15M |
| Total Amortization of Deferred Charges | 310.00K | 250.00K | 217.00K | 75.00K | 110.00K |
| Total Other Non-Cash Items | 5.10M | 8.33M | 7.61M | 9.83M | 13.52M |
| Change in Net Operating Assets | -3.51M | -5.12M | -3.45M | -1.20M | 4.74M |
| Cash from Operations | -37.69M | -38.48M | -36.95M | -38.90M | -35.09M |
| Capital Expenditure | -16.00K | -16.00K | -16.00K | -45.00K | -45.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -16.00K | -16.00K | -16.00K | -45.00K | -45.00K |
| Total Debt Issued | 0.00 | 9.87M | 9.87M | 9.87M | 29.59M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 39.87M | 25.49M | 27.73M | 23.09M | 25.10M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -900.00K | -961.00K | -900.00K | -900.00K | -1.45M |
| Cash from Financing | 38.97M | 34.39M | 36.70M | 32.06M | 53.24M |
| Foreign Exchange rate Adjustments | -56.00K | 22.00K | 48.00K | 171.00K | 168.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.21M | -4.08M | -225.00K | -6.71M | 18.28M |